Table 1. Baseline characteristics according to primary endpoint (first procedure recurrence).
| Characteristic | AF recurrence n = 42 | No AF recurrence n = 50 | P |
|---|---|---|---|
| Age years | 56.0 (22.9) | 60.1 (17.48) | 0.956 |
| BMI kg/m2 | 25.3 (5.0) | 28.9 (6.89) | 0.327 |
| Female sex | 11 (26.2%) | 17 (34.0%) | 0.417 |
| Hypertension | 13 (31.0%) | 18 (36.0%) | 0.610 |
| Diabetes Mellitus | 6 (14.3%) | 3 (6.0%) | 0.183 |
| IHD | 2 (4.8%) | 3 (6.0%) | 0.794 |
| Non-PAF | 15 (35.7%) | 15 (30.0%) | 0.560 |
| Time since 1st AF diagnosis months | 34.3 (33.4) | 24.3 (53.85) | 0.420 |
| CHA2DS2VASc > = 2 | 15 (35.7%) | 20 (40.0%) | 0.673 |
| Mean LA Pressure >11mmHg | 24 (57.1%) | 32 (64.0%) | 0.811 |
| Mean RA Pressure >6mmHg | 23 (54.8%) | 20 (40.0%) | 0.068 |
| LA volume / BSA >28 ml | 24 (57.1%) | 27 (54.0%) | 0.886 |
| LA diameter / BSA >23 mm | 5 (11.9%) | 4 (8.0%) | 0.538 |
| LV EDV / BSA >75 ml | 0 (0.0%) | 2 (4.0%) | 0.204 |
| LV EF <55% | 5 (11.9%) | 3 (6.0%) | 0.285 |
| Mean PIIINP pg/ml (n = 69) | 51.6 (91.1) | 44.9 (115.1) | 0.156 |
| Mean ICTP ng/ml (n = 79) | 329.4 (190.1) | 300.0 (373.0) | 0.121 |
| CS ICTP ng/ml (n = 76) | 297.5 (209.2) | 331.7 (253.6) | 0.314 |
| Mean gal-3 ng/ml (n = 81) | 30.8 (75.4) | 24.5 (40.0) | 0.510 |
| LA gal-3 ng/ml (n = 81) | 18.17 (37.1) | 24.8 (31.6) | 0.709 |
| Mean FGF-23 pg/ml (n = 33) | 32.6 (45.5) | 50.5 (62.8) | 0.313 |
| LA low voltage >30.0%, all participants (n = 92) | 15 (35.7%) | 8 (16.0%) | 0.030 |